Tag Archives: The Stem Cell Blog

Stem cell chief Dr. Maria Millan sheds light on CIRM’s future and potential 2020 bond – San Francisco Business Times

Continue reading

2017-12-08 NEWS

Stem cell chief Dr. Maria Millan sheds light on CIRM’s future and potential 2020 bond
San Francisco Business Times
Eyes have been focused on the California Institute of Regenerative Medicine since California voters in 2004 approved Proposition 71, a $3 billion bond measure to speed research into stem cell therapies and help translate that research into treatments

Continue reading

2017-12-08 NEWS

pharmaphorum

Scotland’s TC BioPharm joins bluebird to develop next-gen CART
pharmaphorum
US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CART cells. As reported by pharmaphorum earlier this year, TC BioPharm has already won EU funding to develop its “off-the-shelf” chimeric antigen

Continue reading

2017-12-08 NEWS

CBS News

DNA is going digital – what could possibly go wrong?
CBS News
We’ve even hosted FBI agents from the Weapons of Mass Destruction Directorate here at Colorado State University and previously at Virginia Tech for crash courses on synthetic biology and the associated cyberbiosecurity risks. A year ago, we

and more »

Continue reading

2017-12-07 NEWS

Endpoints News

Gilead swoops in with $567M deal to buy CART 2.0 player Cell Design Labs
Endpoints News
Gilead has swooped in on the first of several planned new buyouts to build out its CART operations acquired in the $12 billion Kite buyout. And it’s starting with a company that Kite’s Arie Belldegrun believed held the key to the next-gen cell
Genetic Programmers Are the Next Startup MillionairesMIT Technology Review
Gilead Sciences to Acquire Cell Design LabsGlobeNewswire (press release)
Gilead to pop up to $567 million on East Bay ‘smart cell‘ startupSan Francisco Business Times
Reuters –Business Wire (press release) –Nasdaq
all 10 news articles »